To examine the phosphorylation state of MAP1B, which is elevated because of the ALS mutations in UBQLN2, we performed phosphoproteomics of our LCL cell panel (Fig 5A and Table S6). This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.